Article info

Download PDFPDF

Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

Authors

  • Kushan Karunaratne National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Dariush Ahrabian National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Bernadette Monoghan National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Tom Campion Lysholm Department of Neuroradiology and the Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Tarek Yousry Lysholm Department of Neuroradiology and the Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Michael P Lunn MRC Centre for Neuromuscular Disease and Department of Molecular Neuroscience, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UKNIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Michael S Zandi National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UKDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Robin S Howard National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Dimitri M Kullmann National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Jennifer Spillane National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Matthew Walker Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Jeremy Chataway NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UKQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jeremy Chataway; j.chatway{at}ucl.ac.uk
View Full Text

Citation

Karunaratne K, Ahrabian D, Monoghan B, et al
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

Publication history

  • Accepted January 21, 2021
  • First published May 18, 2021.
Online issue publication 
May 18, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.